Advances in Alzheimer’s Disease Drug Development

Alzheimer’s disease (AD) is the foremost cause of dementia worldwide. Clinically, AD manifests as progressive memory impairment followed by a gradual decline in other cognitive abilities leading to complete functional dependency. Recent biomarker studies indicate that AD is characterized by a long a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafii, Michael S, Aisen, Paul S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373002/
https://www.ncbi.nlm.nih.gov/pubmed/25857341
http://dx.doi.org/10.1186/s12916-015-0297-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373002/
https://www.ncbi.nlm.nih.gov/pubmed/25857341
http://dx.doi.org/10.1186/s12916-015-0297-4

Ejemplares similares